What is AQST's dilution risk score?

AQST currently has a DilutionScore of 32/100, indicating medium dilution risk. DilutionWatch monitors AQST SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for AQST?

DilutionWatch tracks 25 SEC filing types for AQST including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect AQST shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For AQST, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for AQST tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for AQST. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

AQST Dilution Risk Score: 32/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

10

📊 Float Risk

7

⚠️ Warrant Exposure

15

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

0%

No significant dilution signals detected for AQST.

🔔 Track AQST — Get forecast alerts →

💹 Market Data

Market Cap$504.31M

Shares Outstanding125.45M

Float114.54M

Cash$110.73M

Debt$45.00M

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 2.4% shares (2026Q1 vs prior)

181 institutional holders · 79.04M shares

#1 Bratton Capital Management, L.P. 9.81M shares

#2 BlackRock, Inc. 7.51M shares

#3 RTW INVESTMENTS, LP 7.43M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest16.00M

Days to Cover5.3

% of Float14.0%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 03, 2026

3 FORM3 Apr 10, 2026

4 INSIDER TRANSACTION Mar 11, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for AQST Shareholders

Aquestive Therapeutics, Inc. (AQST) has a DilutionScore of 32/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch tracks 375,000 outstanding warrants for AQST. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for AQST in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for AQST alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →